Table 5.

ORs and 95% CIs for liver cancer in relation to NFKB1/NFKBIA haplotypes

	All participants*			Female†			Male†
	Cases (%)	Controls (%)	OR (95% CI)	Cases (%)	Controls (%)	OR (95% CI)	Cases (%)	Controls (%)	OR (95% CI)
NFKB1 (rs230525-rs230530)	n=215	n=425	–	n=86	n=165	–	n=129	n=260	–
AG	46.49	52.01	ref	52.14	49.39	ref	42.69	53.53	ref
GA	38.97	35.50	1.23 (0.95 to 1.58)	36.47	36.59	0.94 (0.63 to 1.41)	40.55	34.88	1.46 (1.05 to 2.03)
AA	14.54	12.49	1.30 (0.91 to 1.86)	11.39	14.02	0.77 (0.42 to 1.39)	16.76	11.59	1.81 (1.15 to 2.86)
NFKBIA (rs3138055-rs2273650)
TC	45.00	43.94	ref	48.24	42.31	ref	43.15	45.14	ref
CT	29.05	28.58	1.00 (0.75 to 1.31)	31.30	31.21	0.88 (0.57 to 1.35)	27.79	27.12	1.07 (0.75 to 1.55)
CC	25.65	27.00	0.93 (0.70 to 1.24)	20.47	26.48	0.68 (0.42 to 1.10)	28.50	26.95	1.11 (0.77 to 1.60)

*Adjusted for age and sex.

†Adjusted for age.